Peter J. Crowley serves as Executive at PROGENICS PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Peter J. Crowley has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jun 26, 2019 involved exercising options for 40,000 shares valued at $214.0K.
Peter J. Crowley currently holds 50,000 shares of PROGENICS PHARMACEUTICALS INC (PGNX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Peter J. Crowley has been a net neutral trader of PGNX stock. They have purchased $0 and sold $0 worth of shares.
Peter J. Crowley's most recent insider trade was on Jun 26, 2019, when they sold 40,000 shares at $5.35 per share.
Get notified when new Form 4 filings are submitted
| 10,000 |
| $5.33 |
| Discretionary |